Susquehanna International Group
IBB icon

Susquehanna International Group’s iShares Biotechnology ETF IBB Stock Holding History

Susquehanna International Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.8M Sell
223,700
-1,500
-0.7% -$256K ﹤0.01% 1516
2025
Q4 		$38M Buy
225,200
+39,100
+21% +$6.35M ﹤0.01% 1602
2025
Q3 		$26.9M Sell
186,100
-409,200
-69% -$55.9M ﹤0.01% 1893
2025
Q2 		$75.3M Buy
595,300
+305,700
+106% +$37.5M 0.01% 910
2025
Q1 		$37M Sell
289,600
-62,100
-18% -$8.42M 0.01% 1221
2024
Q4 		$46.5M Sell
351,700
-112,100
-24% -$15.8M 0.01% 1174
2024
Q3 		$67.5M Sell
463,800
-100,400
-18% -$14.5M 0.01% 870
2024
Q2 		$77.4M Buy
564,200
+319,100
+130% +$42.6M 0.01% 715
2024
Q1 		$33.6M Sell
245,100
-214,700
-47% -$29.3M 0.01% 1310
2023
Q4 		$62.5M Buy
459,800
+92,200
+25% +$11.2M 0.01% 914
2023
Q3 		$45M Sell
367,600
-23,000
-6% -$2.92M 0.01% 1081
2023
Q2 		$49.6M Sell
390,600
-573,300
-59% -$74.5M 0.01% 1000
2023
Q1 		$124M Buy
963,900
+656,200
+213% +$85.9M 0.03% 507
2022
Q4 		$40.4M Sell
307,700
-64,600
-17% -$8.35M 0.01% 1012
2022
Q3 		$43.8M Buy
372,300
+102,500
+38% +$12.7M 0.01% 875
2022
Q2 		$31.7M Sell
269,800
-142,300
-35% -$16.9M 0.01% 1115
2022
Q1 		$53.7M Sell
412,100
-260,600
-39% -$33.9M 0.01% 975
2021
Q4 		$103M Sell
672,700
-108,000
-14% -$16.7M 0.02% 701
2021
Q3 		$126M Sell
780,700
-259,000
-25% -$43.6M 0.02% 682
2021
Q2 		$170M Buy
1,039,700
+172,700
+20% +$26.6M 0.02% 574
2021
Q1 		$131M Sell
867,000
-963,600
-53% -$153M 0.02% 603
2020
Q4 		$277M Buy
1,830,600
+615,000
+51% +$87.9M 0.05% 323
2020
Q3 		$165M Buy
1,215,600
+306,900
+34% +$41.6M 0.03% 391
2020
Q2 		$124M Buy
908,700
+482,200
+113% +$61.5M 0.03% 428
2020
Q1 		$46M Sell
426,500
-471,900
-53% -$54.3M 0.01% 689
2019
Q4 		$108M Sell
898,400
-460,600
-34% -$51.4M 0.03% 455
2019
Q3 		$135M Buy
1,359,000
+131,300
+11% +$13.7M 0.05% 351
2019
Q2 		$134M Sell
1,227,700
-58,300
-5% -$6.2M 0.05% 325
2019
Q1 		$144M Buy
1,286,000
+545,400
+74% +$59.8M 0.06% 276
2018
Q4 		$71.4M Sell
740,600
-57,300
-7% -$6.08M 0.03% 474
2018
Q3 		$97.3M Sell
797,900
-146,700
-16% -$17.3M 0.03% 445
2018
Q2 		$104M Buy
944,600
+97,300
+11% +$10.4M 0.04% 403
2018
Q1 		$90.4M Sell
847,300
-304,900
-26% -$33.8M 0.03% 428
2017
Q4 		$123M Sell
1,152,200
-990,100
-46% -$106M 0.04% 354
2017
Q3 		$238M Sell
2,142,300
-887,400
-29% -$94.8M 0.09% 183
2017
Q2 		$313M Buy
3,029,700
+1,819,800
+150% +$179M 0.14% 113
2017
Q1 		$118M Sell
1,209,900
-77,400
-6% -$7.41M 0.06% 283
2016
Q4 		$114M Sell
1,287,300
-1,605,300
-55% -$146M 0.06% 292
2016
Q3 		$279M Buy
2,892,600
+216,900
+8% +$20.6M 0.13% 115
2016
Q2 		$230M Sell
2,675,700
-66,300
-2% -$5.95M 0.12% 130
2016
Q1 		$238M Buy
2,742,000
+98,100
+4% +$8.77M 0.13% 118
2015
Q4 		$298M Sell
2,643,900
-702,000
-21% -$76.2M 0.14% 126
2015
Q3 		$338M Buy
3,345,900
+532,800
+19% +$63.9M 0.15% 112
2015
Q2 		$346M Buy
2,813,100
+339,000
+14% +$40.6M 0.15% 103
2015
Q1 		$283M Buy
2,474,100
+167,400
+7% +$18.5M 0.13% 130
2014
Q4 		$233M Buy
2,306,700
+241,200
+12% +$23.4M 0.09% 203
2014
Q3 		$188M Sell
2,065,500
-12,600
-0.6% -$1.11M 0.07% 231
2014
Q2 		$178M Buy
2,078,100
+476,100
+30% +$37.5M 0.08% 207
2014
Q1 		$126M Buy
1,602,000
+673,200
+72% +$56.1M 0.06% 287
2013
Q4 		$70.3M Buy
928,800
+122,400
+15% +$8.68M 0.03% 497
2013
Q3 		$56.3M Sell
806,400
-394,800
-33% -$25.9M 0.03% 546
2013
Q2 		$69.6M Buy
+1,201,200
New +$69.4M 0.04% 409

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's IBB Position: Q1 2026 in Review

Susquehanna International Group reduced its iShares Biotechnology ETF (IBB) stake by 80% in Q1 2026, selling an estimated $41.5M and leaving 61,634 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3054.

Susquehanna International Group first reported a position in IBB in Q2 2013 and has held it in 47 quarters since. The position peaked at $80.7M in Q2 2014. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Susquehanna International Group held 61,634 shares of iShares Biotechnology ETF worth $10.4M as of Q1 2026.
  • Susquehanna International Group sold 242,512 iShares Biotechnology ETF shares in Q1 2026, an estimated $41.5M.
  • iShares Biotechnology ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3054 holding.
  • Susquehanna International Group first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's iShares Biotechnology ETF position peaked at $80.7M in Q2 2014.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.